Huron Consulting Group Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on July 8, 2008, by Huron Consulting Group Inc. The filing details the completion of a major acquisition, an amendment to a prior stock purchase agreement, and a significant amendment to the company's credit facility to finance these transactions.
Key Financial Metrics and Transaction Details
- Acquisition of Stockamp & Associates, Inc.:
- Total Initial Purchase Price: Approximately $219 million.
- Cash Consideration: Approximately $169 million.
- Stock Consideration: Approximately $50 million (1,100,740 shares of common stock).
- Escrow: 330,222 shares valued at $15 million held in escrow for indemnification.
- Wellspring Amendment:
- Consideration: $20 million paid via issuance of 440,296 shares of common stock.
- Reason: Compensation for ceding the revenue cycle portion of Wellspring's business to Stockamp effective January 1, 2009.
- Debt and Liquidity:
- Revolving Credit Facility: Up to $240 million (includes $20 million sublimit for letters of credit and $15 million for swingline loans).
- Term Loan: Up to $220 million (fully drawn on July 8, 2008).
- Total Debt Outstanding: $347 million following the acquisition financing.
- Weighted-Average Interest Rate: 6.5%.
- Financial Covenants: Debt-to-EBITDA ratio not to exceed 3.25x (stepping down to 3.00x after June 30, 2009); EBITDAR coverage ratio not less than 2.50x.
Material Changes and Contingent Consideration
The filing reports material changes to the company's capital structure and asset base. The acquisition of Stockamp, a management consulting firm for hospitals, significantly expands Huron's healthcare practice. The company incurred $164 million in new borrowings to fund the cash portion of the Stockamp acquisition.
Several contingent payment obligations were established:
- Stockamp Contingent Payment: Potential payment of up to $35 million (less stock value) six months post-closing if stock value is below threshold.
- Stockamp Escrow Release: Potential payment of up to $15 million (less stock value) upon release of escrow shares.
- Stockamp Earn-Out: Payments based on EBITDA multiples for the period ending December 31, 2011. The aggregate amount is not determinable but could be significant.
- Wellspring Contingent Payment: Potential payment of up to $20 million (less stock value) six months post-amendment if stock value is below threshold.
Outlook, Risks, and Unusual Items
The company expects to utilize the remaining balance of its Senior Credit Facilities for working capital, capital expenditures, and other corporate purposes. The filing includes standard forward-looking statements regarding future performance, noting that actual results may differ due to risks outlined in the company's Form 10-K.
Unusual items include the specific earn-out structures tied to stock price performance and EBITDA thresholds, which create variable future liabilities. The financial statements and pro forma information for the Stockamp acquisition are not included in this filing but are scheduled to be filed by September 23, 2008.
Investor Verification Checklist
- Verify the pro forma financial impact of the Stockamp acquisition once filed by September 23, 2008.
- Monitor the company's stock price to determine potential cash or stock payments for the Stockamp and Wellspring contingent consideration clauses.
- Review future quarterly reports to ensure compliance with the 3.25x debt-to-EBITDA covenant.
- Assess the integration progress of Stockamp's hospital consulting practice and the transition of Wellspring's revenue cycle business.
- Confirm the total debt service obligations given the 6.5% weighted-average interest rate on $347 million of debt.